Media ReleasesINOVIQ

View All INOVIQ News

BARD1 Life sciences - Results of 2021 Annual General Meeting

BARD1 Life Sciences Limited (ASX:BD1) (BARD1 or the Company) held the 2021 Annual General Meeting (AGM) yesterday, 29 November 2021, at 2.00pm (ADST).

Voting for all resolutions tabled at the AGM was conducted by poll. In accordance with Listing Rule 3.13.2 and section 251AA of the Corporations Act 2001, details of the resolutions and proxies received for the meeting are set out in the attached proxy summary. 

For more information, download the attached PDF.

Download this document

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.